Daniel Flynn, Esq. Greenbaum Rowe Smith & Davis, LLP, Roseland
Our informative lunchtime webinar reviews two significant developments in environmental law - The congressional push to get the EPA to set drinking water standards for PFOS/PFAS/PFOA and EPA’s new regulatory scheme for management and disposal of hazardous waste pharmaceuticals and new guidance intended to help retailers deal with hazardous waste.
PFOS/PFAS/PFOA are chemicals once used in everyday household products such as rugs, cookware, and food packaging, with known links to health problems. Earlier regulations phased out many of these chemicals from manufacturing, but their presence in water supplies persist, and Congress has been pushing the EPA to establish maximum contaminant levels for the substances so that utilities will have to test for them and remove them from their water supplies. Recently, the EPA pulled back on its intent to regulate the thousands of chemicals included in these categories, so many are anticipating Congressional pressure on the agency. Some states, including New Jersey, are addressing the issue on their own.
Our program will also review a new set of EPA Resource, Conservation and Recovery Act (RCRA) regulations issued in December and relating to the management of hazardous waste pharmaceuticals. Among other things, the new regulations create a “reverse distribution” system to make it easier for pharmacies, hospitals, physician offices, and other “health care facilities” to manage pharmaceuticals that have to be disposed and qualify as hazardous waste. This reverse distribution system applies only to health care facilities and “reverse distributors.” It also does not affect the requirements for waste pharmaceuticals that are not hazardous waste. However, retailers not affected by the new regulation should nonetheless read the preamble because EPA announced a policy that covers the use of reverse logistics for unsold retail items no longer wanted by the retailer.
Our expert panel will review how these developments are likely to impact your environmental and business clients.
• RCRA treatment of nonhazardous waste pharmaceuticals and hazardous waste pharmaceuticals managed by entities other than health care facilities and reverse distributors
• The new policy for retailers on reverse logistics for disposal of unsold retail items other than hazardous waste pharmaceuticals
Warranties for Seminars and Publications
NJSBA and NJICLE products are created by attorneys, doctors, dignitaries and other legal experts who volunteer their efforts to serve as lecturers and authors. We do not warrant the accuracy, reliability or currentness of the information contained in our programs (both live and electronic), handbooks and publications.